Joao Paulo Steffens
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Joao Paulo Steffens has a total of 163 co-authors. Here are the top co-authors by number of shared publications:
- Luis Carlos Spolidorio
Universidade Estadual Paulista, Brazil
14 shared publications - Carlos Rossa
Department of Diagnosis and Surgery, School of Dentistry at Araraquara, São Paulo State University (UNESP), Araraquara, Brazil
8 shared publications - Rafael Scaf de Molon
Department of Diagnostic and Surgery, School of Dentistry São Paulo State University (UNESP) Araçatuba Brazil
6 shared publications - Alex Nogueira Haas
Universidade Federal do Rio Grande do Sul, Brazil
4 shared publications Fábio André Santos
4 shared publicationsGibson Luiz Pilatti
4 shared publications
Latest Publications
- Open Access
- 25 August 2026
- Published by Wiley in Periodontology 2000
Metabolic reprogramming of the immune response in periodontitis
Objective: Periodontitis, a highly prevalent chronic inflammatory disease, is characterized by the progressive destruction of the tooth‐supporting tissues, ultimately causing tooth loss. In recent years, the emerging field of immunometabolism has revealed that immune cell function is tightly regulated by intracellular metabolic pathways that govern cellular activation, differentiation, and effector responses. Therefore, the aim of this review was to synthesize current evidence on the role of immunometabolism in the pathogenesis of periodontitis, with a particular focus on how metabolic reprogramming regulates innate and adaptive immune responses, contributes to inflammatory bone loss, and represents a potential target for host‐modulatory therapies. Materials and Methods: A comprehensive narrative review of the contemporary literature was conducted to integrate experimental, translational, and clinical evidence on immunometabolic mechanisms involved in periodontitis. The review examines metabolic regulation of innate and adaptive immune cells, the influence of microbial and systemic metabolic signals on periodontal inflammation, and emerging therapeutic strategies targeting immunometabolic pathways. Results: Current evidence demonstrates that persistent microbial challenge and inflammatory signaling induce profound metabolic reprogramming of immune cells within the periodontal microenvironment. Activated neutrophils, macrophages, dendritic cells, and lymphocytes undergo coordinated shifts in glycolysis, mitochondrial oxidative phosphorylation, fatty acid oxidation, and amino acid metabolism, which regulate immune cell activation, differentiation, and effector functions. These metabolic adaptations promote the production of reactive oxygen species, pro‐inflammatory cytokines, and osteoclastogenic mediators, thereby amplifying inflammation and disrupting osteoimmune mechanisms that maintain bone homeostasis. In addition, microbial‐derived metabolites further influence host immune metabolism, reinforcing chronic inflammation and periodontal tissue destruction. Emerging preclinical evidence suggests that pharmacological modulation of key immunometabolic pathways may attenuate inflammation and preserve periodontal tissues. Conclusion: Immunometabolic reprogramming is a fundamental mechanism linking microbial dysbiosis to dysregulated host immunity and inflammatory bone loss in periodontitis. A better understanding of the metabolic pathways governing immune cell function may provide important mechanistic insights into disease pathogenesis. By integrating insights from (osteo‐)immunology and metabolism, this review proposes immunometabolism as a critical determinant of inflammatory bone loss and a fruitful avenue for the development of novel host‐modulatory periodontal therapies aimed at restoring immune homeostasis and preventing periodontal tissue destruction.
- 25 August 2026
- Published by Wiley in Periodontology 2000
Open AccessMetabolic reprogramming of the immune response in periodontitis
Objective: Periodontitis, a highly prevalent chronic inflammatory disease, is characterized by the progressive destruction of the tooth‐supporting tissues, ultimately causing tooth loss. In recent years, the emerging field of immunometabolism has revealed that immune cell function is tightly regulated by intracellular metabolic pathways that govern cellular activation, differentiation, and effector responses. Therefore, the aim of this review was to synthesize current evidence on the role of immunometabolism in the pathogenesis of periodontitis, with a particular focus on how metabolic reprogramming regulates innate and adaptive immune responses, contributes to inflammatory bone loss, and represents a potential target for host‐modulatory therapies. Materials and Methods: A comprehensive narrative review of the contemporary literature was conducted to integrate experimental, translational, and clinical evidence on immunometabolic mechanisms involved in periodontitis. The review examines metabolic regulation of innate and adaptive immune cells, the influence of microbial and systemic metabolic signals on periodontal inflammation, and emerging therapeutic strategies targeting immunometabolic pathways. Results: Current evidence demonstrates that persistent microbial challenge and inflammatory signaling induce profound metabolic reprogramming of immune cells within the periodontal microenvironment. Activated neutrophils, macrophages, dendritic cells, and lymphocytes undergo coordinated shifts in glycolysis, mitochondrial oxidative phosphorylation, fatty acid oxidation, and amino acid metabolism, which regulate immune cell activation, differentiation, and effector functions. These metabolic adaptations promote the production of reactive oxygen species, pro‐inflammatory cytokines, and osteoclastogenic mediators, thereby amplifying inflammation and disrupting osteoimmune mechanisms that maintain bone homeostasis. In addition, microbial‐derived metabolites further influence host immune metabolism, reinforcing chronic inflammation and periodontal tissue destruction. Emerging preclinical evidence suggests that pharmacological modulation of key immunometabolic pathways may attenuate inflammation and preserve periodontal tissues. Conclusion: Immunometabolic reprogramming is a fundamental mechanism linking microbial dysbiosis to dysregulated host immunity and inflammatory bone loss in periodontitis. A better understanding of the metabolic pathways governing immune cell function may provide important mechanistic insights into disease pathogenesis. By integrating insights from (osteo‐)immunology and metabolism, this review proposes immunometabolism as a critical determinant of inflammatory bone loss and a fruitful avenue for the development of novel host‐modulatory periodontal therapies aimed at restoring immune homeostasis and preventing periodontal tissue destruction.
- 1 June 2026
- Published by Edizioni Minerva Medica in The Journal of Sports Medicine and Physical Fitness
- Vol. 66 (7)
The effects of anabolic-androgenic steroids administration on oral health in humans: a scoping review
This scoping review aimed to evaluate the effects of anabolic-androgenic steroids (AAS) administration on oral health in humans, distinguishing between medical indications (e.g., replacement therapy) and abuse, while mapping their impact on oral conditions and identifying gaps in knowledge. A systematic search was conducted using PubMed, Cochrane Library, and Virtual Health Library databases. Search terms included keywords related to AAS, testosterone and specific oral health conditions such as dental caries, tooth loss/edentulism, periodontal disease, oral trauma, and oral cancer. Studies were screened and selected based on inclusion criteria: adult humans, AAS use and reported oral health outcomes, with findings interpreted separately according to medical indication (replacement vs. abuse). After screening, eight studies met the inclusion criteria. In the context of AAS abuse, users exhibited poorer periodontal health, with higher rates of severe periodontitis, increased gingival inflammation, and greater gingival thickness. Oral trauma studies indicated a higher frequency of temporomandibular dysfunction and malocclusion among users. A severe adverse event (Stevens-Johnson Syndrome) was also reported in one case of AAS abuse. Conversely, studies addressing medical indications found that therapeutic AAS administration was associated with reduced mucosal toxicity, decreased pain, and remission of aphthous lesions. No studies evaluating dental caries, tooth loss/edentulism, or cleft lip and palate were identified. The effect of AAS on human oral health is critically dependent on the context of administration. AAS abuse is associated with significant oral pathology, notably the increased severity of periodontal disease and risk of severe mucocutaneous adverse events. Conversely, AAS administered under medical indication demonstrated therapeutic potential in reducing treatment-related toxicity (e.g., in oral cancer) and promoting the resolution of recurrent soft tissue lesions (e.g., aphthous ulcers). It is recommended that future studies adopt well-designed sampling strategies in longitudinal studies to enhance clinicians' and researchers' understanding of its effects and mechanisms, ultimately enabling evidence-based recommendations or advisories for or against its use for oral conditions. Health professionals should be aware of the distinct oral health risks and benefits associated with AAS. AAS abuse represents a critical risk factor for severe periodontal pathology and potential mucocutaneous adverse events. Conversely, low-level evidence supports recognizing the therapeutic potential of medically indicated AAS as supportive care for conditions like chemotherapy/radiotherapy-induced mucositis and recurrent soft tissue lesions. Identifying gaps in the literature highlights the need for broader research to ensure the safe monitoring of individuals who use these substances.
- 1 June 2026
- Published by Edizioni Minerva Medica in The Journal of Sports Medicine and Physical Fitness
- Vol. 66 (7)
The effects of anabolic-androgenic steroids administration on oral health in humans: a scoping review
This scoping review aimed to evaluate the effects of anabolic-androgenic steroids (AAS) administration on oral health in humans, distinguishing between medical indications (e.g., replacement therapy) and abuse, while mapping their impact on oral conditions and identifying gaps in knowledge. A systematic search was conducted using PubMed, Cochrane Library, and Virtual Health Library databases. Search terms included keywords related to AAS, testosterone and specific oral health conditions such as dental caries, tooth loss/edentulism, periodontal disease, oral trauma, and oral cancer. Studies were screened and selected based on inclusion criteria: adult humans, AAS use and reported oral health outcomes, with findings interpreted separately according to medical indication (replacement vs. abuse). After screening, eight studies met the inclusion criteria. In the context of AAS abuse, users exhibited poorer periodontal health, with higher rates of severe periodontitis, increased gingival inflammation, and greater gingival thickness. Oral trauma studies indicated a higher frequency of temporomandibular dysfunction and malocclusion among users. A severe adverse event (Stevens-Johnson Syndrome) was also reported in one case of AAS abuse. Conversely, studies addressing medical indications found that therapeutic AAS administration was associated with reduced mucosal toxicity, decreased pain, and remission of aphthous lesions. No studies evaluating dental caries, tooth loss/edentulism, or cleft lip and palate were identified. The effect of AAS on human oral health is critically dependent on the context of administration. AAS abuse is associated with significant oral pathology, notably the increased severity of periodontal disease and risk of severe mucocutaneous adverse events. Conversely, AAS administered under medical indication demonstrated therapeutic potential in reducing treatment-related toxicity (e.g., in oral cancer) and promoting the resolution of recurrent soft tissue lesions (e.g., aphthous ulcers). It is recommended that future studies adopt well-designed sampling strategies in longitudinal studies to enhance clinicians' and researchers' understanding of its effects and mechanisms, ultimately enabling evidence-based recommendations or advisories for or against its use for oral conditions. Health professionals should be aware of the distinct oral health risks and benefits associated with AAS. AAS abuse represents a critical risk factor for severe periodontal pathology and potential mucocutaneous adverse events. Conversely, low-level evidence supports recognizing the therapeutic potential of medically indicated AAS as supportive care for conditions like chemotherapy/radiotherapy-induced mucositis and recurrent soft tissue lesions. Identifying gaps in the literature highlights the need for broader research to ensure the safe monitoring of individuals who use these substances.
- Open Access
- 9 April 2026
- Published by Wiley in Periodontology 2000
- Vol. 99 (1) , 311-331
The role of neutrophils in the pathophysiology of inflammatory bowel diseases
Objectives: Inflammatory bowel disease (IBD) encompasses a spectrum of chronic disorders of the gastrointestinal tract, with a potential bidirectional relationship with periodontitis. Neutrophils are key regulators of immune‐inflammatory responses and play a major role in both diseases. Isolating and characterizing gut lumen neutrophils may help to map the evolution of cell phenotypes from peripheral blood to saliva and help explain certain mechanistic relationships within the oral‐gut axis. This review aims to critically evaluate the biological sources of human neutrophils and the emerging analytical approaches to their study in IBD. Materials and Methods: Studies employing various methodological strategies to isolate and analyze neutrophils derived from both systemic (peripheral blood) and mucosal compartments in IBD are synthesized. Data obtained through different analytical modalities are discussed. Results: Neutrophils play multifaceted roles in IBD beyond their traditional function in pathogen clearance and acute inflammation. They contribute to both tissue injury and repair through the release of proteolytic enzymes, reactive oxygen species, cytokines, and neutrophil extracellular traps. Recent advances in analytical technologies have uncovered remarkable phenotypic and functional diversity, shaped by the local microenvironment within the intestinal mucosa. Conclusions: Neutrophils' ability to both exacerbate mucosal damage and facilitate resolution of inflammation underscores the need for improved methodological approaches that enable precise characterization of their functional states in both systemic and tissue contexts. Clinical Relevance: Improved phenotypic and functional profiling of neutrophils may facilitate the identification of biomarkers predictive of disease activity, treatment response, and relapse risk, and contribute to the understanding of the role of neutrophils in the interplay between IBD and periodontitis.
- 9 April 2026
- Published by Wiley in Periodontology 2000
- Vol. 99 (1) , 311-331
Open AccessThe role of neutrophils in the pathophysiology of inflammatory bowel diseases
Objectives: Inflammatory bowel disease (IBD) encompasses a spectrum of chronic disorders of the gastrointestinal tract, with a potential bidirectional relationship with periodontitis. Neutrophils are key regulators of immune‐inflammatory responses and play a major role in both diseases. Isolating and characterizing gut lumen neutrophils may help to map the evolution of cell phenotypes from peripheral blood to saliva and help explain certain mechanistic relationships within the oral‐gut axis. This review aims to critically evaluate the biological sources of human neutrophils and the emerging analytical approaches to their study in IBD. Materials and Methods: Studies employing various methodological strategies to isolate and analyze neutrophils derived from both systemic (peripheral blood) and mucosal compartments in IBD are synthesized. Data obtained through different analytical modalities are discussed. Results: Neutrophils play multifaceted roles in IBD beyond their traditional function in pathogen clearance and acute inflammation. They contribute to both tissue injury and repair through the release of proteolytic enzymes, reactive oxygen species, cytokines, and neutrophil extracellular traps. Recent advances in analytical technologies have uncovered remarkable phenotypic and functional diversity, shaped by the local microenvironment within the intestinal mucosa. Conclusions: Neutrophils' ability to both exacerbate mucosal damage and facilitate resolution of inflammation underscores the need for improved methodological approaches that enable precise characterization of their functional states in both systemic and tissue contexts. Clinical Relevance: Improved phenotypic and functional profiling of neutrophils may facilitate the identification of biomarkers predictive of disease activity, treatment response, and relapse risk, and contribute to the understanding of the role of neutrophils in the interplay between IBD and periodontitis.
- Open Access
- 8 March 2026
- Published by Wiley in Journal of Periodontal Research
- Vol. 61 (6) , 733-735
Diagnosing and Treating Periodontitis and Multimorbidity Altogether: The Case Example of the Physical Exercise Hormone Irisin
Irisin is an extracellular peptide stimulated by exercise and could act as both a biomarker and mediate the positive impact of exercise. This scoping review synthesizes human evidence on irisin variations in non-communicable diseases, showing an increase of irisin in saliva and gingival tissues in periodontitis, potentially reflecting reparative or immunomodulatory activity.
- 8 March 2026
- Published by Wiley in Journal of Periodontal Research
- Vol. 61 (6) , 733-735
Open AccessDiagnosing and Treating Periodontitis and Multimorbidity Altogether: The Case Example of the Physical Exercise Hormone Irisin
Irisin is an extracellular peptide stimulated by exercise and could act as both a biomarker and mediate the positive impact of exercise. This scoping review synthesizes human evidence on irisin variations in non-communicable diseases, showing an increase of irisin in saliva and gingival tissues in periodontitis, potentially reflecting reparative or immunomodulatory activity.
- Open Access
- 6 March 2026
- Published by Georg Thieme Verlag KG in International Journal of Sports Medicine
Exercise Improves Periodontal Repair Following Ligature-induced Periodontitis in Rats
Periodontitis is a chronic inflammatory condition that involves bone resorption and leads to tooth loss. This study aimed to evaluate the biological plausibility of exercise’s potential impact on periodontal repair in rats. Forty-eight male Wistar rats received cotton ligatures around the lower first molars bilaterally. After 7 days, all animals were allocated to the following groups: control (ligature removal), early treatment (ligature removal+exercise) and late treatment (exercise alone for 28 days and then ligature removal; n=16 per group). All groups were evaluated at 28 and 56 days. Swimming exercise was performed 5 days/wk. Mandibles, blood and gingiva were collected for radiographic, histological and inflammatory analysis using multiplex. At 56 days, both exercise groups showed significantly lower bone loss compared to the control group. Histological analysis revealed that early treatment promoted increased percentages of fibroblasts and blood vessels. Late treatment provided statistically higher serum vascular endothelial growth factor levels than early treatment or control groups. In gingiva, the epidermal growth factor level was significantly higher in the exercise groups compared to the control. In conclusion, late or early treatment including exercise improved bone repair in rats, possibly through growth factor modulation.
- 6 March 2026
- Published by Georg Thieme Verlag KG in International Journal of Sports Medicine
Open AccessExercise Improves Periodontal Repair Following Ligature-induced Periodontitis in Rats
Periodontitis is a chronic inflammatory condition that involves bone resorption and leads to tooth loss. This study aimed to evaluate the biological plausibility of exercise’s potential impact on periodontal repair in rats. Forty-eight male Wistar rats received cotton ligatures around the lower first molars bilaterally. After 7 days, all animals were allocated to the following groups: control (ligature removal), early treatment (ligature removal+exercise) and late treatment (exercise alone for 28 days and then ligature removal; n=16 per group). All groups were evaluated at 28 and 56 days. Swimming exercise was performed 5 days/wk. Mandibles, blood and gingiva were collected for radiographic, histological and inflammatory analysis using multiplex. At 56 days, both exercise groups showed significantly lower bone loss compared to the control group. Histological analysis revealed that early treatment promoted increased percentages of fibroblasts and blood vessels. Late treatment provided statistically higher serum vascular endothelial growth factor levels than early treatment or control groups. In gingiva, the epidermal growth factor level was significantly higher in the exercise groups compared to the control. In conclusion, late or early treatment including exercise improved bone repair in rats, possibly through growth factor modulation.
- Top Cited PapersOpen Access
- 20 January 2026
- Published by Wiley in Journal of Periodontal Research
- Vol. 61 (2) , 138-164
Adjunctive Therapies in Periodontitis: Current Concepts and the Future
Periodontitis is a chronic, host‐mediated inflammatory disease in which microbial dysbiosis and dysregulated immune responses drive the destruction of tooth‐supporting tissues. Although conventional therapy remains centered on mechanical biofilm control, persistent inflammation and alveolar bone loss in susceptible individuals underscore the need for adjunctive strategies. Translating preclinical discoveries into predictable clinical outcomes, however, remains a major challenge in periodontal research. This narrative review integrates two interrelated themes, translational research methodology and adjunctive therapeutic innovation, to critically examine how preclinical findings can be more effectively bridged to clinical practice in periodontitis management. Evidence was synthesized from experimental, translational, and clinical studies retrieved from PubMed, Scopus, and Web of Science up to September 2025. Emphasis was placed on mechanistic insights, model validity, and translational feasibility across host‐modulatory, natural, probiotic, and device‐based adjuncts. Animal models remain indispensable for mechanistic understanding and therapeutic testing but face biological and methodological limitations that hinder direct extrapolation to humans. Interspecies differences, short disease kinetics, and non‐standardized endpoints constrain translational predictability. Addressing these gaps requires refined modeling, standardized outcomes, and integration of systemic risk factors. Within this methodological framework, several adjunctive modalities, including specialized pro‐resolving mediators, probiotics, natural compounds such as curcumin and resveratrol, and device‐based therapies like antimicrobial photodynamic therapy demonstrate promising anti‐inflammatory, osteoimmunomodulatory, and regenerative effects. Emerging translational tools such as bioresponsive drug delivery systems, nanocarriers, 3D‐printed scaffolds, and AI‐driven precision periodontics may further enhance clinical relevance and patient‐specific targeting. Advancing adjunctive periodontal therapy demands harmonized translational models, bioresponsive delivery platforms, and precision diagnostic tools that bridge preclinical efficacy with real‐world outcomes. By aligning methodological rigor with therapeutic innovation, translational research can accelerate the safe and effective clinical integration of next‐generation adjunctive treatments in periodontitis.
- 20 January 2026
- Published by Wiley in Journal of Periodontal Research
- Vol. 61 (2) , 138-164
Top Cited PapersOpen AccessAdjunctive Therapies in Periodontitis: Current Concepts and the Future
Periodontitis is a chronic, host‐mediated inflammatory disease in which microbial dysbiosis and dysregulated immune responses drive the destruction of tooth‐supporting tissues. Although conventional therapy remains centered on mechanical biofilm control, persistent inflammation and alveolar bone loss in susceptible individuals underscore the need for adjunctive strategies. Translating preclinical discoveries into predictable clinical outcomes, however, remains a major challenge in periodontal research. This narrative review integrates two interrelated themes, translational research methodology and adjunctive therapeutic innovation, to critically examine how preclinical findings can be more effectively bridged to clinical practice in periodontitis management. Evidence was synthesized from experimental, translational, and clinical studies retrieved from PubMed, Scopus, and Web of Science up to September 2025. Emphasis was placed on mechanistic insights, model validity, and translational feasibility across host‐modulatory, natural, probiotic, and device‐based adjuncts. Animal models remain indispensable for mechanistic understanding and therapeutic testing but face biological and methodological limitations that hinder direct extrapolation to humans. Interspecies differences, short disease kinetics, and non‐standardized endpoints constrain translational predictability. Addressing these gaps requires refined modeling, standardized outcomes, and integration of systemic risk factors. Within this methodological framework, several adjunctive modalities, including specialized pro‐resolving mediators, probiotics, natural compounds such as curcumin and resveratrol, and device‐based therapies like antimicrobial photodynamic therapy demonstrate promising anti‐inflammatory, osteoimmunomodulatory, and regenerative effects. Emerging translational tools such as bioresponsive drug delivery systems, nanocarriers, 3D‐printed scaffolds, and AI‐driven precision periodontics may further enhance clinical relevance and patient‐specific targeting. Advancing adjunctive periodontal therapy demands harmonized translational models, bioresponsive delivery platforms, and precision diagnostic tools that bridge preclinical efficacy with real‐world outcomes. By aligning methodological rigor with therapeutic innovation, translational research can accelerate the safe and effective clinical integration of next‐generation adjunctive treatments in periodontitis.
- Top Cited PapersOpen Access
- 3 January 2026
- Published by Springer Nature in Bone Research
- Vol. 14 (1) , 1
Inflammatory bone loss and signaling pathways in periodontitis: mechanistic insights and emerging therapeutic strategies
Bone resorption is a vital physiological process that enables skeletal remodeling, maintenance, and adaptation to mechanical forces throughout life. While tightly regulated under the physiological state, its dysregulation contributes to pathological conditions such as osteoporosis, rheumatoid arthritis, and periodontitis. Periodontitis is a highly prevalent chronic inflammatory disease driven by dysbiotic biofilms that disrupt the oral microbiome, leading to the progressive breakdown of the periodontal ligament, cementum, and alveolar bone and ultimately resulting in tooth loss. This review outlines the molecular and cellular mechanisms underlying periodontitis, focusing on osteoclastogenesis, the differentiation and activation of osteoclasts, the primary mediators of bone resorption. Key transcriptional regulators, including NFATc1, c-Fos, and c-Src are discussed alongside major signaling pathways such as Mitogen Activated Protein Kinase (MAPK), Janus Tyrosine Kinase/Signal Transducer and Activator of Transcription (JAK/STAT), Nuclear Factor Kappa B (NF-κB), and Phosphoinositide 3-kinase (PI3K)/Akt, to elucidate their roles in the initiation and progression of periodontal bone loss. These pathways orchestrate the inflammatory response and osteoclast activity, underscoring their relevance in periodontitis and other osteolytic conditions. Hallmark features of periodontitis, including chronic inflammation, immune dysregulation, and tissue destruction are highlighted, with emphasis on current and emerging therapeutic strategies targeting these molecular pathways. Special attention is given to small molecules, biologics, and natural compounds that have the potential to modulate key signaling pathways. Although advances in understanding these mechanisms have identified promising therapeutic targets, translation into effective clinical interventions remains challenging. Continued research into regulating bone-resorptive signaling pathways is essential for developing more effective treatments for periodontitis and related inflammatory bone diseases.
- 3 January 2026
- Published by Springer Nature in Bone Research
- Vol. 14 (1) , 1
Top Cited PapersOpen AccessInflammatory bone loss and signaling pathways in periodontitis: mechanistic insights and emerging therapeutic strategies
Bone resorption is a vital physiological process that enables skeletal remodeling, maintenance, and adaptation to mechanical forces throughout life. While tightly regulated under the physiological state, its dysregulation contributes to pathological conditions such as osteoporosis, rheumatoid arthritis, and periodontitis. Periodontitis is a highly prevalent chronic inflammatory disease driven by dysbiotic biofilms that disrupt the oral microbiome, leading to the progressive breakdown of the periodontal ligament, cementum, and alveolar bone and ultimately resulting in tooth loss. This review outlines the molecular and cellular mechanisms underlying periodontitis, focusing on osteoclastogenesis, the differentiation and activation of osteoclasts, the primary mediators of bone resorption. Key transcriptional regulators, including NFATc1, c-Fos, and c-Src are discussed alongside major signaling pathways such as Mitogen Activated Protein Kinase (MAPK), Janus Tyrosine Kinase/Signal Transducer and Activator of Transcription (JAK/STAT), Nuclear Factor Kappa B (NF-κB), and Phosphoinositide 3-kinase (PI3K)/Akt, to elucidate their roles in the initiation and progression of periodontal bone loss. These pathways orchestrate the inflammatory response and osteoclast activity, underscoring their relevance in periodontitis and other osteolytic conditions. Hallmark features of periodontitis, including chronic inflammation, immune dysregulation, and tissue destruction are highlighted, with emphasis on current and emerging therapeutic strategies targeting these molecular pathways. Special attention is given to small molecules, biologics, and natural compounds that have the potential to modulate key signaling pathways. Although advances in understanding these mechanisms have identified promising therapeutic targets, translation into effective clinical interventions remains challenging. Continued research into regulating bone-resorptive signaling pathways is essential for developing more effective treatments for periodontitis and related inflammatory bone diseases.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Oral Research
- Vol. 40 (suppl 1)
E-cigarettes and periodontal health: current evidence and research gaps
Cigarette smoking is a well-established risk factor for periodontitis, contributing to increased clinical attachment loss (CAL), alveolar bone loss, and impaired treatment response. As electronic cigarettes (ECs) are increasingly used as alternatives to combustible tobacco, questions remain regarding their adverse effects on oral and periodontal health. This critical review integrated evidence from experimental, cross-sectional, longitudinal and interventional studies to evaluate the relationship between EC use and periodontal health. Experimental and molecular studies supported biological plausibility for periodontal harm, indicating that aerosols can induce oxidative stress, upregulate pro-inflammatory mediators, and disrupt host-microbial interactions. Cross-sectional studies generally reported poorer periodontal conditions among EC users compared with never-smokers, including higher plaque index and periodontal probing depth, although results for CAL and alveolar bone loss were inconsistent. Comparisons between EC users and cigarette smokers often showed more favorable clinical parameters among EC users. Longitudinal evidence continued to be limited. The only prospective cohort study reported higher CAL among EC users than never-smokers and observed an increase in CAL over time exclusively in EC users. Interventional studies assessing response to periodontal therapy have yielded inconsistent results, with some suggesting a poorer treatment response among EC users and others finding no significant differences. Overall, there were Well-designed longitudinal studies with clearly defined exposure groups, standardized periodontal outcomes, and longer follow-up are needed to clarify whether EC use independently contributes to periodontal deterioration.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Oral Research
- Vol. 40 (suppl 1)
Open AccessE-cigarettes and periodontal health: current evidence and research gaps
Cigarette smoking is a well-established risk factor for periodontitis, contributing to increased clinical attachment loss (CAL), alveolar bone loss, and impaired treatment response. As electronic cigarettes (ECs) are increasingly used as alternatives to combustible tobacco, questions remain regarding their adverse effects on oral and periodontal health. This critical review integrated evidence from experimental, cross-sectional, longitudinal and interventional studies to evaluate the relationship between EC use and periodontal health. Experimental and molecular studies supported biological plausibility for periodontal harm, indicating that aerosols can induce oxidative stress, upregulate pro-inflammatory mediators, and disrupt host-microbial interactions. Cross-sectional studies generally reported poorer periodontal conditions among EC users compared with never-smokers, including higher plaque index and periodontal probing depth, although results for CAL and alveolar bone loss were inconsistent. Comparisons between EC users and cigarette smokers often showed more favorable clinical parameters among EC users. Longitudinal evidence continued to be limited. The only prospective cohort study reported higher CAL among EC users than never-smokers and observed an increase in CAL over time exclusively in EC users. Interventional studies assessing response to periodontal therapy have yielded inconsistent results, with some suggesting a poorer treatment response among EC users and others finding no significant differences. Overall, there were Well-designed longitudinal studies with clearly defined exposure groups, standardized periodontal outcomes, and longer follow-up are needed to clarify whether EC use independently contributes to periodontal deterioration.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista Brasileira de Epidemiologia
- Vol. 29 (suppl 1)
Relação entre cobertura de atenção primária e secundária com doença periodontal no Brasil: um estudo multinível
RESUMO Objetivo: Avaliar os efeitos independentes e conjuntos da presença de Centros de Especialidades Odontológicas (CEOs) e cobertura de atenção primária em saúde na Doença Periodontal (DP) entre adultos e idosos no Brasil. Métodos: Dados do inquérito SB Brasil 2023 foram obtidos para 7.851 indivíduos que utilizaram serviços públicos. Variáveis contextuais foram obtidas de sistemas de informação em saúde e do Instituto Brasileiro de Geografia e Estatística (IBGE). A variável de desfecho foi DP, definida como ter >1 dente com profundidade de sondagem >3 mm. As principais exposições foram a presença de CEOs e a cobertura da Atenção Primária em Saúde Bucal (eSB APS). Análises de regressão logística multinível foram realizadas. Resultados: A prevalência ponderada de DP foi de 17,4%; e, respectivamente, 19,4 e 11,9% (p=0,03) em municípios com e sem CEO. Municípios com cobertura populacional de eSB APS<50%, 50–74%, 75–99% e 100% apresentaram prevalências, respectivamente, de 19,3, 21,1, 18,1 e 7,7% (p=0,01). Indivíduos em municípios com CEOs apresentaram maior chance de desenvolver DP [OR 1,12 (IC95% 0,75–1,68)]. Indivíduos em municípios com 100% de cobertura de eSB APS apresentaram OR 0,57 (IC95% 0,29–1,12) menos chances de DP em comparação aos municípios com <50% na presença de CEO. Na ausência dos CEOs, o respectivo OR foi 0,43 (IC95% 0,19–97), mas a interação CEO e eSB APS não foi significativa (p=0,90). Conclusão: Maior cobertura de atenção primária em saúde bucal parece estar independentemente associada a menor prevalência de DP em cidades de pequeno e médio porte. Estudos futuros devem investigar as barreiras no sistema de encaminhamento.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista Brasileira de Epidemiologia
- Vol. 29 (suppl 1)
Open AccessRelação entre cobertura de atenção primária e secundária com doença periodontal no Brasil: um estudo multinível
RESUMO Objetivo: Avaliar os efeitos independentes e conjuntos da presença de Centros de Especialidades Odontológicas (CEOs) e cobertura de atenção primária em saúde na Doença Periodontal (DP) entre adultos e idosos no Brasil. Métodos: Dados do inquérito SB Brasil 2023 foram obtidos para 7.851 indivíduos que utilizaram serviços públicos. Variáveis contextuais foram obtidas de sistemas de informação em saúde e do Instituto Brasileiro de Geografia e Estatística (IBGE). A variável de desfecho foi DP, definida como ter >1 dente com profundidade de sondagem >3 mm. As principais exposições foram a presença de CEOs e a cobertura da Atenção Primária em Saúde Bucal (eSB APS). Análises de regressão logística multinível foram realizadas. Resultados: A prevalência ponderada de DP foi de 17,4%; e, respectivamente, 19,4 e 11,9% (p=0,03) em municípios com e sem CEO. Municípios com cobertura populacional de eSB APS<50%, 50–74%, 75–99% e 100% apresentaram prevalências, respectivamente, de 19,3, 21,1, 18,1 e 7,7% (p=0,01). Indivíduos em municípios com CEOs apresentaram maior chance de desenvolver DP [OR 1,12 (IC95% 0,75–1,68)]. Indivíduos em municípios com 100% de cobertura de eSB APS apresentaram OR 0,57 (IC95% 0,29–1,12) menos chances de DP em comparação aos municípios com <50% na presença de CEO. Na ausência dos CEOs, o respectivo OR foi 0,43 (IC95% 0,19–97), mas a interação CEO e eSB APS não foi significativa (p=0,90). Conclusão: Maior cobertura de atenção primária em saúde bucal parece estar independentemente associada a menor prevalência de DP em cidades de pequeno e médio porte. Estudos futuros devem investigar as barreiras no sistema de encaminhamento.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista Brasileira de Epidemiologia
- Vol. 29 (suppl 1)
Relation between primary and secondary health care coverage with periodontal disease in Brazil: a multilevel study
Objective: To evaluate the independent and combined effects of the presence of Dental Specialty Centers (Centros de Especialidades Odontológicas – CEOs) and primary health care coverage on Periodontal Disease (PD) among adults and older adults in Brazil. Methods: Data from the SB Brasil 2023 survey were obtained for 7,851 individuals who used public services. Contextual variables were obtained from health information systems and the Brazilian Institute of Geography and Statistics (Instituto Brasileiro de Geografia e Estatística – IBGE). The outcome variable was PD, defined as having >1 tooth with probing depth >3 mm. The main exposures were the presence of CEOs and the coverage of Primary Oral Health Care (PHC-OH). Multilevel logistic regression analyses were performed. Results: The weighted prevalence of PD was 17.4%; and, respectively, 19.4% and 11.9% (p=0.03) in municipalities with and without CEOs. Municipalities with PHC-OH population coverage of ≤50, 50–74, 75–99%, and 100% showed prevalences of 19.3, 21.1, 18.1, and 7.7%, respectively (p=0.01). Individuals in municipalities with CEOs had higher odds of developing PD [OR 1.12 (95% CI 0.75–1.68)]. Individuals in municipalities with 100% PHC-OH coverage had OR 0.57 (95% CI 0.29–1.12), indicating lower odds of PD compared to municipalities with <50% coverage in the presence of CEOs. In the absence of CEOs, the corresponding OR was 0.43 (95%CI 0.19–0.97), but the interaction between CEO and PHC-OH was not significant (p=0.90). Conclusion: Greater coverage of primary oral health care appears to be independently associated with a lower prevalence of PD in small- and medium-sized cities. Future studies should investigate barriers in the referral system.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista Brasileira de Epidemiologia
- Vol. 29 (suppl 1)
Open AccessRelation between primary and secondary health care coverage with periodontal disease in Brazil: a multilevel study
Objective: To evaluate the independent and combined effects of the presence of Dental Specialty Centers (Centros de Especialidades Odontológicas – CEOs) and primary health care coverage on Periodontal Disease (PD) among adults and older adults in Brazil. Methods: Data from the SB Brasil 2023 survey were obtained for 7,851 individuals who used public services. Contextual variables were obtained from health information systems and the Brazilian Institute of Geography and Statistics (Instituto Brasileiro de Geografia e Estatística – IBGE). The outcome variable was PD, defined as having >1 tooth with probing depth >3 mm. The main exposures were the presence of CEOs and the coverage of Primary Oral Health Care (PHC-OH). Multilevel logistic regression analyses were performed. Results: The weighted prevalence of PD was 17.4%; and, respectively, 19.4% and 11.9% (p=0.03) in municipalities with and without CEOs. Municipalities with PHC-OH population coverage of ≤50, 50–74, 75–99%, and 100% showed prevalences of 19.3, 21.1, 18.1, and 7.7%, respectively (p=0.01). Individuals in municipalities with CEOs had higher odds of developing PD [OR 1.12 (95% CI 0.75–1.68)]. Individuals in municipalities with 100% PHC-OH coverage had OR 0.57 (95% CI 0.29–1.12), indicating lower odds of PD compared to municipalities with <50% coverage in the presence of CEOs. In the absence of CEOs, the corresponding OR was 0.43 (95%CI 0.19–0.97), but the interaction between CEO and PHC-OH was not significant (p=0.90). Conclusion: Greater coverage of primary oral health care appears to be independently associated with a lower prevalence of PD in small- and medium-sized cities. Future studies should investigate barriers in the referral system.